1. Home
  2. NLSP vs AUDC Comparison

NLSP vs AUDC Comparison

Compare NLSP & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • AUDC
  • Stock Information
  • Founded
  • NLSP 2015
  • AUDC 1992
  • Country
  • NLSP Switzerland
  • AUDC Israel
  • Employees
  • NLSP N/A
  • AUDC N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • NLSP Health Care
  • AUDC Utilities
  • Exchange
  • NLSP Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • NLSP 243.8M
  • AUDC 266.8M
  • IPO Year
  • NLSP 2021
  • AUDC 1999
  • Fundamental
  • Price
  • NLSP $3.37
  • AUDC $8.72
  • Analyst Decision
  • NLSP
  • AUDC Buy
  • Analyst Count
  • NLSP 0
  • AUDC 2
  • Target Price
  • NLSP N/A
  • AUDC $10.00
  • AVG Volume (30 Days)
  • NLSP 626.4K
  • AUDC 107.3K
  • Earning Date
  • NLSP 11-29-2024
  • AUDC 11-06-2024
  • Dividend Yield
  • NLSP N/A
  • AUDC 4.14%
  • EPS Growth
  • NLSP N/A
  • AUDC 0.25
  • EPS
  • NLSP N/A
  • AUDC 0.40
  • Revenue
  • NLSP N/A
  • AUDC $244,181,000.00
  • Revenue This Year
  • NLSP N/A
  • AUDC N/A
  • Revenue Next Year
  • NLSP N/A
  • AUDC $21.93
  • P/E Ratio
  • NLSP N/A
  • AUDC $21.59
  • Revenue Growth
  • NLSP N/A
  • AUDC N/A
  • 52 Week Low
  • NLSP $3.00
  • AUDC $7.70
  • 52 Week High
  • NLSP $29.08
  • AUDC $14.45
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 37.40
  • AUDC 47.92
  • Support Level
  • NLSP $3.01
  • AUDC $8.13
  • Resistance Level
  • NLSP $3.55
  • AUDC $8.76
  • Average True Range (ATR)
  • NLSP 0.43
  • AUDC 0.31
  • MACD
  • NLSP -0.01
  • AUDC 0.05
  • Stochastic Oscillator
  • NLSP 20.98
  • AUDC 64.65

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: